These meetings are sponsored by the American Heart Association and its scientific councils. For information, contact the AHA, Scientific Meetings, 7272 Greenville Ave, Dallas, TX 75231-4596; Fax 214-373-3406; E-mail email@example.com or Web site http://my.americanheart.org/portal/professional/conferencesevents
Feb 2–4: International Stroke Conference 2005. New Orleans, La. The International Stroke Conference encompasses two and a half days of educational forums highlighting recent advances in the treatment, prevention and outcomes of cerebrovascular disease and stroke. More than 450 posters and oral presentations and lectures will be featured. Special symposia this year will focus on several topics, including: the impact of hypertension, hyperglycemia, and hyperthermia in the acute phase of stroke; novel interventions for the treatment of intracranial aneurysms; evolving approaches to treat intracranial hemorrhage; use of ultrasounds as an acute treatment for stroke; translational research in nursing; primary prevention for stroke; stroke and sleep disturbances; telemedicine and stroke; and more. Sessions from the clinical categories include diagnosis, acute management, in-hospital treatment, rehabilitation and recovery, prevention and community/risk factors, and outcomes. Experimental categories include neurons/glia/inflammation and vascular pathophysiology/thrombosis. http://strokeconference.americanheart.org.
Feb 16–19: 2nd International Conference on Women, Heart Disease and Stroke. Orlando, Fla. The conference is jointly sponsored by the American Heart Association, the Centers for Disease Control and Prevention, the American College of Cardiology Foundation, the World Heart Federation, the National Heart, Lung, and Blood Institute, and the Heart and Stroke Foundation of Canada. This two-and-a-half day program will present plenary and concurrent oral and poster sessions that will explore the reasons for the disturbing trends that most impact the progression of cardiovascular diseases, provide state-of-the art aspects of the behavioral, pharmacological, and public policy approaches to the prevention, treatment, and management of these diseases. We will also discuss the policy perspectives that have international application.
Feb 17–20: 8th International Kawasaki Disease Symposium. San Diego, Calif. Sponsored by the American Heart Association’s councils on Cardiovascular Disease in the Young, Clinical Cardiology, and Cardiovascular Radiology and Intervention. Co-sponsored by the Kawasaki Disease Foundation and the Japan Kawasaki Disease Research Center. The 8th International Kawasaki Disease Symposium will bring together scientists and clinicians from around the world to discuss Kawasaki disease research and clinical management on a broad scale. The major clinical focus will be to review the clinical case definition and facilitate the timely treatment of all children at risk for coronary artery complications. Additional areas of emphasis will include the following: (1) new therapeutic agents for management of acute Kawasaki disease and its chronic cardiovascular complications; (2) new developments in cardiovascular imaging techniques; (3) advances in the understanding of genetic influences on disease susceptibility, response to therapy, and clinical outcome; and (4) application of molecular techniques, including reverse genetics, epitope library screening, and understanding the etiology and pathogenesis of Kawasaki disease.
April 28–30: 6th Annual Conference on Arteriosclerosis, Thrombosis, and Vascular Biology. Washington, DC. This two-and-one-half day meeting is sponsored by the Council on Arteriosclerosis, Thrombosis and Vascular Biology and the Council on Nutrition, Physical Activity and Metabolism. The meeting will focus on new developing research opportunities in arteriosclerosis, thrombosis and vascular biology. The conference includes special lectures, discussions, and oral and poster presentations. The meeting format provides opportunities for intense interaction among the participants during the sessions and breaks. The goal of this meeting is to bring together diverse disciplines within the arteriosclerosis, thrombosis and vascular biology research communities to allow investigators to explore areas of cross-disciplinary interest. The program encourages cross-fertilization by examining new and emerging areas in lipids and lipoproteins, arteriosclerosis, thrombosis and vascular biology in an informal setting. Sessions planned by each of the representative areas, ie, arteriosclerosis, thrombosis, vascular biology, and nutrition/physical activity/metabolism, will provide an opportunity for oral presentations of abstracts. We hope that the interdisciplinary approach will serve as a template for future meetings that encompass a broad view of arteriosclerosis, thrombosis and vascular biology.
April 29-May 2: 45th Annual Conference on Cardiovascular Disease Epidemiology and Prevention in association With the Council on Nutrition, Physical Activity, and Metabolism. Washington, DC. The scientific program of the 45th American Heart Association Annual Conference on Cardiovascular Disease Epidemiology and Prevention in association with the Council on Nutrition, Physical Activity, and Metabolism provides physicians, epidemiologists, biostatisticians, dietitians, nutritional scientists, exercise physiologists, psychologists, nurses, school health professionals, and other health scientists the opportunity to learn current information about: (1) population trends in cardiovascular diseases and their risk factors; (2) causes and mechanisms of atherosclerosis and other cardiovascular diseases; (3) results of cardiovascular disease treatment and prevention trials; (4) methods of population surveillance for cardiovascular disease and risk factors; (5) techniques in preventive cardiology; (6) nutrition and cardiovascular disease; and (7) outcomes research in cardiovascular disease.
May 14–16: 6th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke. Washington, DC. This two-day conference will feature plenary, breakout and poster sessions. The 6th Scientific Forum will focus on new and developing opportunities, initiatives, projects, policies, and research that are relevant to the measurement and improvement of the quality of care and outcomes for persons with or at risk for cardiovascular disease and stroke. The forum fosters informal interaction among attendees and provides networking opportunities for early career investigators.
July 16–20: 5th Hypertension Summer School. Castine, Me. This course, designed both for trainees and junior faculty in the basic science field and for fellows in clinical training, will provide a 4-day intensive learning experience. It will focus on the understanding of the molecular, cellular, genetic, and pathophysiological bases of hypertension, as well as the clinical epidemiology, pathology, and treatment of high blood pressure.
July 24–29: 2nd Annual Symposium of the American Heart Association Council on Basic Cardiovascular Sciences: Targeting Heart Failure: New Science, New Tools, New Strategies. Keystone, Colo. This annual meeting is the second for this research conference sponsored by the AHA Council on Basic Cardiovascular Sciences. This conference aims to enhance the understanding of normal and abnormal cardiovascular biology—integrating insights from gene and molecules through to the intact organism. Prior meetings focused on the molecular mechanisms underlying cardiac signaling and regeneration and in particular the central role that functional genomics plays to our advancing knowledge about the heart and vascular system. For this second meeting, we turn the spotlight on heart failure—exploring new mechanistic paradigms, advanced methodological approaches, and novel therapeutic strategies that are evolving to treat it. Heart failure in its various forms and presentations is the leading cause of cardiovascular morbidity and mortality and a dominant target of health care resources. Recent strides in structure-function molecular biology, signaling, cell life and death cycle biology, regenerative and gene transfer therapies, and mechanical and non-pharmacologic interventions are rapidly changing the scientific and therapeutic landscape. The worldwide impact of this disease will continue to emphasize broadly applicable and relatively low-cost approaches to stave off or reverse progressive disease. The goal of this meeting is to bring together scientists representing the major active fronts in the battle against heart failure.
July 24-Aug 6: 31st Ten-Day Seminar on the Epidemiology and Prevention of Cardiovascular Disease. Tahoe City, Calif. The primary goal of the seminar is to provide an intensive introduction to the epidemiology and prevention of major cardiovascular diseases for qualified health professionals planning careers in research, teaching or practice in this area. Faculty in epidemiology, preventive cardiology, and biostatistics will present a series of discussions, lectures and laboratory and tutorial sessions to illustrate basic principles and their application, with extensive group participation. Up to 20 faculty members and 30 selected candidates will participate in the seminar. Candidates must be at the postdoctoral level with some residency training or its equivalent. Applications must be received by Friday, March 18, 2005.
Sept 8–13: Six-Day Symposium on Congenital Heart Disease Development, Pathology, Imaging, and Surgery. Albuquerque, NM.
Sept 21–24: 59th Annual Fall Conference and Scientific Sessions of the Council for High Blood Pressure Research in association with the Council on the Kidney in Cardiovascular Disease. Washington, DC. The conference is a two-and-one-half-day scientific program that gives physicians and research investigators an opportunity to enhance their knowledge, advance their skills, and learn about the latest developments in research pertaining to hypertension, stroke, kidney function, obesity, and genetics. The program will include state-of-the-art lectures and more than 350 oral and poster abstract presentations and discussions led by authorities. CME credit will be provided.
Other Meetings of Interest—Domestic
Feb 24–26: Cardiovascular Topics at Johns Hopkins. Baltimore, Md. The annual Hopkins course is for cardiologists, general practitioners, and internists seeking a comprehensive review of the year’s most topical issues. The program is clinically oriented, including case presentations, updates on clinical practice, and reviews of multicenter trials data, but with an emphasis on the scientific underpinnings of cardiology practice. For more information, e-mail firstname.lastname@example.org.
April 1–3: Annual Advanced Topics in CT Scanning: CT Angiography, 3D Imaging, Virtual Imaging Principles, Techniques, and Clinical Applications. Los Angeles, Calif. The rapid evolution of Spiral CT into Multislice or Multidetector CT (MDCT) provides the radiologist with unprecedented capabilities to acquire high-resolution CT datasets. Applications such as CT angiography are becoming more mainstream and promise to be the next frontier in CT scanning. This course addresses the principles, exam techniques, and clinical applications in 3D imaging and CT angiography. This is done through a series of lectures, panel discussions, and hands-on experience with a state-of-the-art real-time imaging workstation. For more information, e-mail email@example.com.
Other Meetings of Interest—Abroad
July 16–19: 12th World Congress on Heart Disease: New Trends in Research, Diagnosis, and Treatment. Vancouver, BC, Canada. The Congress will provide the opportunity for a comprehensive overview of the latest research developments in cardiovascular medicine, primarily in the areas of molecular biology, coronary artery disease, heart failure, cardiac arrhythmias and cardiac surgery. Program areas will range from clinical pathophysiology to evaluation and stratification techniques and molecular and cellular biology, including neurohumoral, immunological and genetic studies. We will discuss new and innovative diagnostic methods, prevention and treatment of heart disease, and prognostic algorithms. Integrated into the program will be an update on the latest major clinical trials. For more information, visit http://www.cardiologyonline.com/wchd05/WCHD_index.htm.
The American Heart Association welcomes announcements of interest to physicians, scientists, researchers, and others concerned with cardiovascular and cerebrovascular medicine. All copy is reviewed by the Scientific Publishing Department and Science and Medicine Resources. Content may be edited for style, clarity, and length. Copy should be sent to Publications–AHA News & Meetings Calendar, American Heart Association, Scientific Councils, 7272 Greenville Ave, Dallas, TX 75231-4596; Fax 214-691-6342; E-mail Scientific.Publishing@heart.org.